Mankind Pharma Limited — Capital/Financing Update 2024

Aug 6, 2024

==> picture [559 x 53] intentionally omitted <==

Date: August 6, 2024

BSE Limited P J Towers, Dalal Street, Mumbai – 400 001

Script Code: 543904

National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051

Symbol: MANKIND

Dear Sir/ Madam,

Subject: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Intimation of reaffirmation of Credit Rating

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that CRISIL Ratings Limited vide their letter dated August 5, 2024 has reaffirmed the credit rating for the following instrument:

Credit RatingCompany	Instrument	Amount(₹ crore)	Rating	RatingAction
CRISILRatingsLimited	Non-ConvertibleDebentures	4,600.00	CRISIL AA+/Stable	Reaffirmed

The above information is also available on the website of the Company at www.mankindpharma.com.

This is for your information and records.

Thanking You,

Yours Faithfully,

For Mankind Pharma Limited

PRADEEP Digitally signed by PRADEEP CHUGH CHUGH Date: 2024.08.06 17:50:22 +05'30' Pradeep Chugh Company Secretary and Compliance Officer

==> picture [557 x 60] intentionally omitted <==